Finance

Lists
C68:FRA
Crescent Biopharma Inc
€13.40
+4.69%
(+0.60) 1D
Aug 7, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C68...
Open
€13.40
High
€13.40
Low
€13.40
Mkt. cap
625.50M
Avg. vol.
1.00
Volume
0.00
52-wk high
€22.80
52-wk low
€6.70
No. of employees
69
Open
€13.40
High
€13.40
Low
€13.40
Mkt. cap
625.50M
Avg. vol.
1.00
Volume
0.00
52-wk high
€22.80
52-wk low
€6.70
No. of employees
69
About Crescent Biopharma Inc
CEO-
Employees69
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
10.84M
1.04M
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.35M
95.03M
17.90M
19.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.54M
7.31M
7.86M
8.74M
Operating expense
25.88M
102.34M
25.77M
28.13M
Total operating expenses
25.88M
102.34M
25.77M
28.13M
Operating income
-25.88M
-91.49M
-24.73M
-28.13M
Other non operating income
-
-
-
-
EBT including unusual items
-24.61M
-90.40M
-23.28M
-24.84M
EBT excluding unusual items
-24.61M
-90.40M
-23.28M
-26.61M
Income tax expense
-
2.00M
-
-
Effective tax rate
-
-2.21%
-
-
Other operating expenses
-
-
-
-
Net income
-24.61M
-92.40M
-23.28M
-24.84M
Net profit margin
-
-852.06%
-2,240.90%
-
Earnings per share
-1.37
-4.92
-0.70
-0.62
Interest and investment income
1.28M
1.10M
1.45M
1.53M
Interest expense
-
-
-
-
Net interest expenses
1.28M
1.10M
1.45M
1.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.86M
-91.44M
-24.66M
-28.07M
Gain or loss from assets sale
-
-
-
-1.77M
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps